Formulations For Small Intestinal Delivery Of Rsv And Norovirus Antigens

Patent No. EP3307239 (titled "Formulations For Small Intestinal Delivery Of Rsv And Norovirus Antigens") was filed by Vaxart on Jun 8, 2016. The application was issued on Sep 16, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IOSBIOJun 15, 2021LEONARD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3307239

VAXART
Application Number
EP16808196A
Filing Date
Jun 8, 2016
Status
Granted And Under Opposition
Aug 14, 2020
Publication Date
Sep 16, 2020